Chronic Kidney Disease (CKD) Drugs Market to Reach USD 23.8 Billion by 2034, Driven by Rising Disease Prevalence and New Drug Approvals
The global chronic kidney disease (CKD) drugs market is witnessing steady growth as the prevalence of kidney disorders continues to rise worldwide and pharmaceutical companies expand their portfolios of renal therapies. According to the latest industry analysis, the global CKD drugs market was valued at US$ 14.8 billion in 2023 and is projected to reach US$ 23.8 billion by the end of 2034,...
0 Comments 0 Shares 159 Views 0 Reviews